IP Library › Patent Application 62967271
Patent Application Provisional Small
App. No. 62/967,271 · Confirmation No. 7175

TREATMENT OF LEUKEMIAS AND LYMPHOMAS WITH COMBINATIONS OF BCL-2 INHIBITORS AND PLK1 INHIBITORS

Applicant: Trovagene, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2024-09-12 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2024-09-12 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2024-09-05 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-09-05 PA.. Power of Attorney 1 View
2020-10-22 R3.73 Assignee showing of ownership per 37 CFR 3.73 3 View
2020-10-22 ADS Application Data Sheet 1 View
2020-10-22 R46C.REQ Request under 37CFR1.46(c) to correct, update, change applicant 1 View
2020-10-22 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-10-13 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2020-10-07 PA.. Power of Attorney 2 View
2020-10-07 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-02-06 APP.FILE.REC Filing Receipt 3 View
2020-01-29 ADS Application Data Sheet 8 View
2020-01-29 WFEE Fee Worksheet (SB06) 2 View
2020-01-29 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-01-29 SPEC Specification 16 View
2020-01-29 CLM Claims 2 View
2020-01-29 ABST Abstract 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/967,271
Filed
2020-01-29